These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1681103)
1. Study of a restriction fragment length polymorphism for serum amyloid P gene in rheumatoid arthritis with amyloidosis. Grateau G; Baudis M; Delpech M J Rheumatol; 1991 Jul; 18(7):994-6. PubMed ID: 1681103 [TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268 [TBL] [Abstract][Full Text] [Related]
3. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644 [TBL] [Abstract][Full Text] [Related]
4. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis. Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360 [TBL] [Abstract][Full Text] [Related]
5. A genetic marker for systemic amyloidosis in juvenile arthritis. Woo P; O'Brien J; Robson M; Ansell BM Lancet; 1987 Oct; 2(8562):767-9. PubMed ID: 2443773 [TBL] [Abstract][Full Text] [Related]
6. Lack of association of a restriction fragment length polymorphism for serum amyloid P gene with reactive amyloidosis. Harats N; Kluve-Beckerman B; Skinner M; Passo M; Quinn L; Benson MD Arthritis Rheum; 1989 Oct; 32(10):1325-7. PubMed ID: 2478136 [TBL] [Abstract][Full Text] [Related]
7. Variant mannose-binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritis. Maury CP; Aittoniemi J; Tiitinen S; Laiho K; Kaarela K; Hurme M J Intern Med; 2007 Oct; 262(4):466-9. PubMed ID: 17875183 [TBL] [Abstract][Full Text] [Related]
8. [Molecular genetic, laboratory and clinical study of serum amyloid P]. Biró J; Balogh Z; Szongoth M; Megyeri A; Bély M; Falus A Orv Hetil; 1992 Apr; 133(14):841-5. PubMed ID: 1522987 [TBL] [Abstract][Full Text] [Related]
9. [Rheumatoid arthritis and secondary amyloidosis]. Inada S Ryumachi; 2000 Oct; 40(5):849-56. PubMed ID: 11215164 [No Abstract] [Full Text] [Related]
10. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan. Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052 [TBL] [Abstract][Full Text] [Related]
11. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837 [TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and genetic background of secondary amyloidosis associated with rheumatoid arthritis in Japanese]. Nakai H; Ozaki S; Kano S; Goto M; Komatsubara Y; Kondo S; Shimizu M; Takasugi K; Hanyu T; Matsuno H; Matsubara T; Yamana S Ryumachi; 1996 Feb; 36(1):25-33. PubMed ID: 8711535 [TBL] [Abstract][Full Text] [Related]
13. [Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis]. Okuda Y; Yamada T; Takasugi K; Takeda M; Nanba S; Onishi M; Miyamoto T; Inoue Y Ryumachi; 1999 Feb; 39(1):3-10. PubMed ID: 10332210 [TBL] [Abstract][Full Text] [Related]
14. Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis. Okuda Y; Yamada T; Matsuura M; Takasugi K; Goto M Amyloid; 2011 Sep; 18(3):108-11. PubMed ID: 21627560 [TBL] [Abstract][Full Text] [Related]
15. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596 [TBL] [Abstract][Full Text] [Related]
16. Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Koivuniemi R; Paimela L; Suomalainen R; Tornroth T; Leirisalo-Repo M Amyloid; 2008 Dec; 15(4):262-8. PubMed ID: 19065298 [TBL] [Abstract][Full Text] [Related]
17. [Secondary amyloidosis complicated rheumatoid arthritis, prevalence study in Italian population]. Benucci M; Maniscalchi F; Manfredi M Recenti Prog Med; 2007 Jan; 98(1):16-9. PubMed ID: 17345875 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis. Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465 [TBL] [Abstract][Full Text] [Related]
19. sE-Selectin expression and A561C polymorphism in relation to rheumatoid arthritis clinical activity. Navarro-Hernández RE; Oregón-Romero E; Rangel-Villalobos H; Vázquez-Del Mercado M; Ruiz-Quezada SL; Maldonado-González M; Torres-Vitela R; Muñoz-Valle JF J Rheumatol; 2006 Oct; 33(10):1968-72. PubMed ID: 17014013 [TBL] [Abstract][Full Text] [Related]